Optimizing(O) RIfapentine-based(RI) Regimen and shortENing(EN) the Treatment of Drug-sensitive Tuberculosis(T)

NCT05401071 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

2442

Enrollment

OTHER

Sponsor class

Conditions

Tuberculosis, Pulmonary

Interventions

OTHER: Short Regimen with Rifapentine 10mg/kg
COMBINATION_PRODUCT: Standardized Regimen
OTHER: Short Regimen with Rifapentine 15mg/kg
OTHER: Short Regimen with Rifapentine 20mg/kg

Sponsor

Huashan Hospital